T2 Biosystems, Inc. Operating Lease, Impairment Loss
T2 Biosystems, Inc. reported Operating Lease, Impairment Loss of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseImpairmentLoss · last filed 2022-03-23
- T2 Biosystems, Inc. operating lease, impairment loss for the quarter ending 2020-12-31 was $0.00.
- T2 Biosystems, Inc. operating lease, impairment loss for the quarter ending 2020-09-30 was $0.00.
- T2 Biosystems, Inc. operating lease, impairment loss for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- T2 Biosystems, Inc. operating lease, impairment loss for fiscal 2020 was $523.00K.
- T2 Biosystems, Inc. operating lease, impairment loss for fiscal 2019 was $0.00.
| Period end | Operating Lease, Impairment Loss 3 month | Operating Lease, Impairment Loss 6 month | Operating Lease, Impairment Loss 9 month | Operating Lease, Impairment Loss 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-23 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $0.00 derived: sum of 2 quarters · filed 2022-03-23 | $523.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $523.00K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $523.00K 10-Q · filed 2021-08-09 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 |